Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 2/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.48 |
| ▸ | LMNA | P02545 | 2/20 | 0.48 |
| ▸ | THRB | P10828 | 1/20 | 0.48 |
| ▸ | BLM | P54132 | 1/20 | 0.48 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.48 |
| ▸ | BACE1 | P56817 | 1/20 | 0.47 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.42 |
| ▸ | RXRA | P19793 | 1/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.42 |
| ▸ | ALPL | P05186 | 1/20 | 0.42 |
| ▸ | GAA | P10253 | 1/20 | 0.42 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.41 |
| ▸ | ERN1 | O75460 | 1/20 | 0.41 |
| ▸ | POLB | P06746 | 3/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.40 |
| ▸ | TSHR | P16473 | 1/20 | 0.40 |
| ▸ | TRIM24 | O15164 | 1/20 | 0.40 |
| ▸ | TRIM33 | Q9UPN9 | 1/20 | 0.40 |
| ▸ | XDH | P47989 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31177892 | 1.00 | MEN1 (0.48) | MEN1KMT2ALMNATHRBBLM | |
| SCHEMBL14236880 | 0.90 | HPRT1 (0.52) | MEN1KMT2ALMNATHRBBLM | |
| SCHEMBL1666665 | 0.86 | DNMT1 (0.46) | MEN1KMT2ALMNATHRBBLM | |
| SCHEMBL3962387 | 0.85 | ERN1 (0.50) | MEN1KMT2ALMNATHRBBLM | |
| SCHEMBL15789565 | 0.85 | MEN1 (0.41) | MEN1KMT2ALMNATHRBBLM | |
| SCHEMBL17704125 | 0.85 | MEN1 (0.41) | MEN1KMT2ALMNATHRBBLM | |
| SCHEMBL14236988 | 0.82 | KMT2A (0.43) | MEN1KMT2ALMNATHRBBLM | |
| SCHEMBL35849993 | 0.82 | MEN1 (0.57) | MEN1KMT2ALMNATHRBBLM | |
| SCHEMBL9005 | 0.82 | MEN1 (0.57) | MEN1KMT2ALMNATHRBBLM | |
| SCHEMBL249552 | 0.82 | KMT2A (0.71) | MEN1KMT2ALMNATHRBBLM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 291 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115215763-A | Mass spectrum matrix material and preparation method thereof | 闽江学院 | 2022-10-21 | — | — | CN | claimed |
| CN-115058008-A | Polysulfone polymer and preparation method thereof | 宁夏清研高分子新材料有限公司 | 2022-09-16 | — | — | CN | claimed |
| CN-110437143-B | Benzyl substituted quinoline and derivative and synthesis method thereof | 湘潭大学 | 2022-08-09 | — | — | CN | claimed |
| CN-114870881-A | Seaweed-derived defective carbon material-supported nickel catalyst and application thereof | 青岛大学 | 2022-08-09 | — | — | CN | claimed |
| US-20130315834-A1 | NANOPROBE COMPRISING GOLD COLLOID NANOPARTICLES FOR MULTIMODALITY OPTICAL IMAGING OF CANCER AND TARGETED DRUG DELIVERY FOR CANCER | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2013-11-28 | — | — | US | claimed |
| WO-2012039685-A1 | A NANOPROBE COMPRISING GOLD COLLOID NANOPARTICLES FOR MULTIMODALITY OPTICAL IMAGING OF CANCER AND TARGETED DRUG DELIVERY FOR CANCER | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2012-03-29 | — | — | WO | claimed |
| US-5965591-A | MONOAMINE OXIDASE INHIBITOR; FOR PROPHYLAXIS AND TREATING PARKINSON'S DISEASE, DEPRESSION AND ALZHEIMER'S DISEASE | SANKYO COMPANY, LIMITED (JP) | 1999-10-12 | — | — | US | claimed |
| EP-0563271-A1 | UV/EB CURABLE BUTYL COPOLYMERS FOR COATING APPLICATIONS | EXXON CHEMICAL PATENTS INC. (US) | 1993-10-06 | — | — | EP | claimed |
| WO-1992011295-A1 | UV/EB CURABLE BUTYL COPOLYMERS FOR COATING APPLICATIONS | EXXON CHEMICAL PATENTS INC. (US) | 1992-07-09 | — | — | WO | claimed |
| US-12552779-B2 | 1-alkyl-5-arylidene-2-selenoxoimidazolidine-4-on and derivative thereof, preparation method therefor, and composition comprising same for preventing, alleviating or treating neurodegenerative diseases | DUKSUNG WOMEN'S UNIVERSITY INDUSTRY-ACADEMIC COOPERATION FOUNDATION (KR) | 2026-02-17 | — | — | US | disclosed |
| CN-119504462-A | Calix [4] arene cyclohexanediamine derivative and green method for catalyzing asymmetric Aldol reaction by using same | 常州大学 | 2025-02-25 | — | — | CN | disclosed |
| US-20240358679-A1 | PHARMACEUTICAL AND FOOD COMPOSITIONS FOR THE PREVENTION, ALLEVIATION, OR TREATMENT OF INFLAMMATORY DISEASES COMPRISING 1-ALKYL-5-ARYLIDENE-2-SELENOXOIMIDAZOLIDIN-4-ONE AND ITS DERIVATIVES | INDUSTRY ACADEMIC COOPERATION FOUNDATION OF YEUNGNAM UNIVERSITY (KR) | 2024-10-31 | — | — | US | disclosed |
| CN-115058008-B | Polysulfone polymer and preparation method thereof | 宁夏清研高分子新材料有限公司 | 2024-01-30 | — | — | CN | disclosed |
| CN-114082446-B | Chiral zirconium catalyst for preparing chiral alpha-hydroxy-beta-keto ester compound and preparation method thereof | 南开沧州渤海新区绿色化工研究有限公司 | 2023-12-22 | — | — | CN | disclosed |
| EP-0126541-A1 | Photopolymerization initiator and method of photopolymerization by use of said initiator | NIPPON OIL AND FATS COMPANY, LIMITED (JP) | 1984-11-28 | — | — | EP | disclosed |
| EP-0123842-A1 | Photo-curable epoxy resin type composition | KABUSHIKI KAISHA TOSHIBA (JP) | 1984-11-07 | — | — | EP | disclosed |
| EP-0114258-A1 | Resin encapsulation type photo-semiconductor devices | KABUSHIKI KAISHA TOSHIBA (JP) | 1984-08-01 | — | — | EP | disclosed |
| US-4369207-A | PHOTOPOLYMERIZING | TEIJIN LIMITED (JP) | 1983-01-18 | — | — | US | disclosed |
| US-4254035-A | BY REACTING GLYCINE AND AN AROMATIC ALDEHYDE IN THE PRESENCE OF ACETIC ANHYDRIDE | DEUTSCHE GOLD- UND SILBER-SCHEIDEANSTALT VORMALS ROESSLER (DE) | 1981-03-03 | — | — | US | disclosed |
| EP-0015441-A2 | Laminated film structure of aromatic polyester and process for production thereof | TEIJIN LIMITED (JP) | 1980-09-17 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12552779-B2 | 1-alkyl-5-arylidene-2-selenoxoimidazolidine-4-on and derivative thereof, preparation method therefor, and composition comprising same for preventing, alleviating or treating neurodegenerative diseases | SNCA, HTT, PSEN1 | MEN1 1548/4885KMT2A 2385/4885LMNA 1447/4885 |
| US-20130315834-A1 | NANOPROBE COMPRISING GOLD COLLOID NANOPARTICLES FOR MULTIMODALITY OPTICAL IMAGING OF CANCER AND TARGETED DRUG DELIVERY FOR CANCER | CD47, ALB, HCCS | MEN1 2235/4885KMT2A 4160/4885LMNA 4204/4885 |
| US-20240358679-A1 | PHARMACEUTICAL AND FOOD COMPOSITIONS FOR THE PREVENTION, ALLEVIATION, OR TREATMENT OF INFLAMMATORY DISEASES COMPRISING 1-ALKYL-5-ARYLIDENE-2-SELENOXOIMIDAZOLIDIN-4-ONE AND ITS DERIVATIVES | GPX4, GPX1, SELENOI | MEN1 3057/4885KMT2A 3162/4885LMNA 3007/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.